Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Somnologie
Erschienen in: Somnologie 1/2017

27.02.2017 | Insomnie | Leitlinie

S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen

Kapitel „Insomnie bei Erwachsenen“ (AWMF-Registernummer 063-003), Update 2016

verfasst von: Prof. Dr. D. Riemann, E. Baum, S. Cohrs, T. Crönlein, G. Hajak, E. Hertenstein, P. Klose, J. Langhorst, G. Mayer, C. Nissen, T. Pollmächer, S. Rabstein, A. Schlarb, H. Sitter, H.-G. Weeß, T. Wetter, K. Spiegelhalder

Erschienen in: Somnologie | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Auszug

Im Jahr 2009 wurde von der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin (DGSM) die S3-Leitlinie „Nicht erholsamer Schlaf/Schlafstörungen“ veröffentlicht [1]. Inzwischen hat schlafmedizinisches Wissen in Diagnostik und Therapie so an Umfang zugenommen, dass der Vorstand der DGSM beschlossen hat, Updates der Leitlinie in Teilkapiteln vorzunehmen. Für das Gebiet der Insomnien bei Erwachsenen wurde Prof. Dr. Dieter Riemann vom DGSM-Vorstand beauftragt, federführend zusammen mit der DGSM und weiteren Experten auf dem Gebiet ein Update auf S3-Leitlinienniveau zu erarbeiten. …
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
Literatur
1.
Mayer G, Fietze I, Fischer J, Penzel T, Riemann D, Rodenbeck A, Sitter H, Teschler H (2009) S3-Leitlinie Nicht-erholsamer Schlaf/Schlafstörungen. Somnologie (Berl) 13:1–160
2.
Baglioni C, Spiegelhalder K, Lombardo C, Riemann D (2010) Sleep and emotions: a focus on insomnia. Sleep Med Rev 14:227–238PubMedCrossRef
3.
Bonnet MH, Arand DL (2010) Hyperarousal and insomnia: state of the science. Sleep Med Rev 14:9–15PubMedCrossRef
4.
5.
Ellis JG, Gherman P, Espie CA, Riemann D, Perlis ML (2012) Acute insomnia: current conceptualizations and future directions. Sleep Med Rev 16:5–14PubMedCrossRef
6.
Espie CA, Broomfield NM, MacMahon KM, Macphee LM, Taylor LM (2006) The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review. Sleep Med Rev 10:215–245PubMedCrossRef
7.
Feige B, Baglioni C, Spiegelhalder K, Hirscher V, Nissen C, Riemann D (2013) The microstructure of sleep in primary insomnia: an overview and extension. Int J Psychophysiol 89:171–180PubMedCrossRef
8.
9.
10.
11.
12.
13.
Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK (1997) Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res 6:179–188PubMedCrossRef
14.
Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19–31PubMedCrossRef
15.
Riemann D, Spiegelhalder K, Nissen C, Hirscher V, Baglioni C, Feige B (2012) REM sleep instability – a new pathway for insomnia? Pharmacopsychiatry 45:167–176PubMed
16.
Riemann D, Spiegelhalder K, Espie C, Pollmächer T, Léger D, Bassetti C, van Someren E (2011) Chronic insomnia: clinical and research challenges – an agenda. Pharmacopsychiatry 44:1–14PubMedCrossRef
17.
Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K (2015) The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14:547–558PubMedCrossRef
18.
Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep a‑nd circadian rhythms. Nature 437:1257–1263PubMedCrossRef
19.
20.
21.
Spielman AJ, Caruso LS, Glovinsky PA (1987) A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 10:541–553PubMed
22.
23.
American Psychiatric Association (Hrsg) (2013) DSM 5 (diagnostic and statistical manual of mental disorders). American Psychiatric Association, Washington DC
24.
WHO (1992) Kapitel V–F 51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf
25.
American Academy of Sleep Medicine (Hrsg) (2014) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien
26.
National Institutes of Health (2005) National Institutes of Health state of the science conference statement: manifestations and management of chronic insomnia in adults June 13–15, 2005. Sleep 28:1049–1057
27.
Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, Riemann D (2014) Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 18:195–213PubMedCrossRef
28.
Bastien CH, Vallières A, Morin CM (2001) Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2:297–307PubMedCrossRef
29.
Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49:651–668PubMedCrossRef
30.
Buysse DJ, Reynolds CF, Monk TH et al (1989) The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRef
31.
Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein K, Morin CM (2012) The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 35:287–302PubMedPubMedCentral
32.
Crönlein T, Geisler P, Langguth B, Eichhammer P, Jara C, Pieh C, Zulley J, Hajak G (2012) Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath 16:1097–1103PubMedCrossRef
33.
Feige B, Al-Shajlawi A, Nissen C, Voderholzer U, Hornyak M, Spiegelhalder K, Kloepfer C, Perlis M, Riemann D (2008) Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res 17:180–190PubMedCrossRef
34.
Görtelmeyer R (2005) Schlaffragebogen A und B. In: CIPS: Internationale Skalen für Psychiatrie, 5. Aufl. Beltz PVU, Weinheim, S 537–370
35.
Hoffmann RM, Müller T, Hajak G, Cassel W (1997) Abend-Morgenprotokolle in Schlafforschung und Schlafmedizin – Ein Standardinstrument für den deutschsprachigen Raum. Somnologie (Berl) 1:103–109CrossRef
36.
37.
Liendl S, Hoffmann RM (1999) Compliance-Probleme bei der Bearbeitung von Abend-Morgen-Protokollen – Entwicklung einer Kurzversion der Standardprotokolle der DGSM. Somnologie (Berl) 3:73–77CrossRef
38.
Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ (2007) Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 30:519–529PubMedCrossRef
39.
Ohayon MM, Roth T (2013) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37:9–15CrossRef
40.
Shahid A, Wilkinson K, Marcu S, Shapiro CM (Hrsg) (2012) STOP, THAT and one hundred other sleep scales. Springer, New York
41.
Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Mérette C, Baillargeon L, Grégoire J‑P (2009) The natural history of insomnia. Arch Intern Med 169:447–453PubMedCrossRef
42.
Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6:97–111PubMedCrossRef
43.
Schlack R, Hapke U, Maske U, Busch MA, Cohrs S (2013) Häufigkeit und Verteilung von Schlafproblemen und Insomnie in der deutschen Erwachsenenbevölkerung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 5(6):740–748CrossRef
44.
Thun E, Bjorvatn B, Akerstedt T, Moen BE, Waage S, Molde H, Pallesen S (2016) Trajectories of sleepiness and insomnia symptoms in Norwegian nurses with and without night work and rotational work. Chronobiol Int 33:480–489PubMedCrossRef
45.
Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A (2015) Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev 30:11–24PubMedCrossRef
46.
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135:10–19PubMedCrossRef
47.
Bernert RA, Turvey CL, Conwell Y, Joiner TE (2014) Association of poor subjective sleep quality with risk for death by suicide during a 10-year period – a longitudinal, population-based study of late life. JAMA Psychiatry 71:1129–1137PubMedPubMedCentralCrossRef
48.
Bjørngaard JH, Bjerkeset O, Romundstad P, Gunnell D (2011) Sleeping problems and suicide in 75,000 Norwegian adults: a 20 year follow-up of the HUNT I study. Sleep 34:1155–1159PubMedPubMedCentral
49.
Chen X, Beydoun MA, Wang Y (2008) Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity (Silver Spring) 16:265–274CrossRef
50.
Crönlein T, Langguth B, Busch V, Rupprecht R, Wetter TC (2015) Severe chronic insomnia is not associated with higher body mass index. J Sleep Res 24:514–517PubMedCrossRef
51.
Laugsand LE, Vatten LJ, Platou C, Janszky I (2011) Insomnia and the risk of acute myocardial infarction: a population study. Circulation 124:2073–2081PubMedCrossRef
52.
Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I (2014a) Insomnia and the risk of incident heart failure: A population study. Eur Heart J 35:1382–1393PubMedCrossRef
53.
Laugsand LE, Strand LB, Vatten LJ, Janszky I, Bjørngaard JH (2014b) Insomnia symptoms and risk for unintentional fatal injuries – The HUNT Study. Sleep 37:1777–1786PubMedPubMedCentral
54.
Li M, Zhang X‑W, Hou W‑S, Tang Z‑Y (2014) Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 176:1044–1047PubMedCrossRef
55.
Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K (2014) The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev 3:1–9CrossRef
56.
Mayer G, Jennum P, Riemann D, Cauvilliers Y (2011) Insomnia in central neurologic diseases – occurrence and management. Sleep Med Rev 15:369–378PubMedCrossRef
57.
Meng L, Zheng Y, Hui R (2013) The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res 36:985–995PubMedPubMedCentralCrossRef
58.
Neckelmann D, Mykletun A, Dahl AA (2007) Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30:873–880PubMedPubMedCentral
59.
Palagini L, Bruno RM, Gemignani A, Baglioni C, Ghiadoni L, Riemann D (2013) Sleep loss and hypertension: a systematic review. Curr Pharm Des 19:2409–2419PubMedCrossRef
60.
Patel SR, Hu FB (2008) Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 16:643–653CrossRef
61.
Riemann D, Voderholzer U (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76:255–259PubMedCrossRef
62.
Pigeon WR, Pinquart M, Conner K (2012) Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 73:1160–1167CrossRef
63.
Sexton CE, Storsve AB, Walhovd KB et al (2014) Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology 83:967–973PubMedPubMedCentralCrossRef
64.
Sivertsen B, Øverland S, Pallesen S, Bjorvatn B, Nordnus IH, MÆland JG, Mykletun A (2009a) Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res 18:122–128PubMedCrossRef
65.
Sivertsen B, Øverland S, Bjorvatn B, MÆland JG, Mykletun A (2009b) Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res 66:67–74PubMedCrossRef
66.
Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF (2014) Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 21:57–64PubMedCrossRef
67.
Weissman MM, Greenwald S, Niño-Murcia G, Dement WC (1997) The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19:245–250PubMedCrossRef
68.
Yaffe K, Falvey CM, Hoang T (2014) Connections between sleep and cognition in older adults. Lancet Neurol 13:1017–1028PubMedCrossRef
69.
70.
Daley M, Morin CM, LeBlanc M, Grégoire J‑P, Savard J (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms and good sleepers. Sleep 32:55–64PubMedPubMedCentral
71.
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen H‑C, Stovner LJ, Vallat J‑M, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen H‑U, Jönsson B, Olesen J (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718–779PubMedCrossRef
72.
73.
Ozminkowski RJ, Wang S, Walsh JK (2007) The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30:263–273PubMed
74.
Backhaus J, Hohagen F, Voderholzer U, Riemann D (2001) Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci 251:35–41PubMedCrossRef
75.
Belleville G, Cousineau H, Levrier K, St. Pierre-Delorme ME (2011) Meta-analytic review of the impact of cognitive-behaviour therapy for insomnia on concomitant anxiety. Clin Psychol Rev 31:638–652PubMedCrossRef
76.
Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195–204PubMed
77.
Borbély AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557–568PubMed
78.
Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, Begley A, Houck PR, Mazumdar S, Reynolds CF, Monk TH (2011) Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 171:887–895PubMedPubMedCentralCrossRef
79.
Cheng SK, Dizon J (2012) Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis. Psychother Psychosom 81:206–216PubMedCrossRef
80.
Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, Glozier N, O’Dea B, Hickie IB, Mackinnon AJ (2016) Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry 3(4):333–341. doi:10.​1016/​S2215-0366(15)00536-2 PubMedCrossRef
81.
Crönlein T (2013) Primäre Insomnie – Ein Gruppentherapieprogramm für den stationären Bereich. Hogrefe, Göttingen
82.
Crönlein T, Langguth B, Geisler P, Wetter TC, Eichhammer P (2014) Fourteen-day inpatient cognitive-behavioural therapy for insomnia: a logical and useful extension of the stepped-care approach for the treatment of insomnia. Psychother Psychosom 83:255–256PubMedCrossRef
83.
Ellis JG, Cushing T, Germain A (2015) Treating acute insomnia: a randomized controlled trial of a „single-shot“ of cognitive behavioral therapy for insomnia. Sleep 38:971–978PubMedPubMedCentral
84.
Espie CA, MacMahon KMA, Kelly H‑L, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 30:574–584PubMed
85.
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JSL (2012) A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 35:769–781PubMedPubMedCentralCrossRef
86.
Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M (2015) Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev 23:54–67PubMedCrossRef
87.
Gosling JA, Glozier N, Griffiths K, Ritterband L, Thorndike F, Mackinnon A, Hehir KK, Bennett A, Bennett K, Christensen H (2014) The GoodNight study – online CBT for insomnia for the indicated prevention of depression: study protocol for a randomized controlled trial. Trials 15:56. doi:10.​1186/​1745-6215-15-56 PubMedPubMedCentralCrossRef
88.
Hauri PJ (1991) Case studies in insomnia. Plenum Medical Book Company, New YorkCrossRef
89.
Hertenstein E, Spiegelhalder K, Johann A, Riemann D (2015) Prävention und Psychotherapie der Insomnie. Kohlhammer, Stuttgart
90.
91.
Ho FY, Chung K‑F, Yeung W‑F, Ng TH, Kwan K‑S, Yung K‑P, Cheng SK (2015) Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev 19:17–28PubMedCrossRef
92.
Irwin MR, Cole JC, Nicassio PM (2006) Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults an in older adults 55+ years of age. Health Psychol 25:3–14PubMedCrossRef
93.
Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH (2015) The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev 22:2–36CrossRef
94.
Järnefelt H, Lagerstedt R, Kajaste S, Sallinen M, Savolainen A, Hublin C (2012) Cognitive behavioral therapy for shift workers with chronic insomnia. Sleep Med 13:1238–1246PubMedCrossRef
95.
Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28PubMedCrossRef
96.
Koffel EA, Koffel JB, Gehrman PR (2015) A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev 19:6–16PubMedCrossRef
97.
Lacks P, Rotert M (1986) Knowledge and practice of sleep hygiene techniques in insomniacs and good sleepers. Behav Res Ther 24:365–368PubMedCrossRef
98.
99.
Mitchell MD, Gehrman P, Perlis ML, Umscheid CA (2012) Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic reveiw. BMC Fam Pract 13(40):1–11
100.
Montgomery P, Dennis J (2004) A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 8:47–62PubMedCrossRef
101.
Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, Coleman J, Kapur V, Lee-Chiong T, Owens J, Pancer J, Swick T (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep medicine report. Sleep 29:1415–1419PubMed
102.
Morin CM, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151:1172–1180PubMedCrossRef
103.
Morin CM, Colecchi C, Stone J, Sood R, Brink D (1999) Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 281:991–999PubMedCrossRef
104.
Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L (2009) Cognitive behanvioral therapy, singly and combined with medication, for persistent insomnia. JAMA 301:2005–2015PubMedPubMedCentralCrossRef
105.
Müller T, Paterok B (1999) Schlaftraining – Ein Therapiemanual zur Behandlung von Schlafstörungen. Hogrefe, Göttingen
106.
Murtagh DRR, Greenwood KM (1995) Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 63:79–89PubMedCrossRef
107.
Okajima I, Komada Y, Inoue Y (2011) A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms 9:24–34CrossRef
108.
Pallesen S, Nordhus IH, Kvale G (1998) Nonpharmacological interventions for insomnia in older adults: a meta-analysisn of treatment efficacy. Psychotherapy (Chic) 35:472CrossRef
109.
Riemann D (2016) Ratgeber Schlafstörungen - Informationen für Betroffene und Angehörige, 2. Aufl. Hogrefe, GöttingenCrossRef
110.
Riemann D, Perlis ML (2009) The treatments of chronic insomnia: a review of benzo-diazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 13:205–214PubMedCrossRef
111.
Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, Morin CM (2009) Efficacy of an internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 66:692–698PubMedPubMedCentralCrossRef
112.
Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ (2002) Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159:5–11PubMedCrossRef
113.
Spiegelhalder K, Backhaus J, Riemann D (2011) Schlafstörungen – Fortschritte der Psychotherapie. Hogrefe, Göttingen
114.
Stiftung Warentest (2016) Endlich schlafen. Stiftung Warentest, Berlin
115.
Tang NKY, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP (2015) Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 38:1751–1764PubMedPubMedCentralCrossRef
116.
Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW (2015) Cognitive behavioral therapy for chronic insomnia. Ann Intern Med 163:191–204PubMedCrossRef
117.
Van Straten A, Cuijpers P (2009) Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev 13:61–71PubMedCrossRef
118.
Wu JQ, Appleman ER, Salazar RD, Ong JC (2015) Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions. JAMA Intern Med 175(1461):1472
119.
Ye Y, Zhang Y, Chen J, Liu J, Li X, Liu Y, Lang Y, Lin L, Yang X, Jiang X (2015) Internet-based cognitive behavioral therapy for insomnia (ICBT-I) improves comorbid anxiety and depression – a meta-analysis of randomized controlled trials. PLOS ONE 10:eO142258. doi:10.​1371/​journal.​pone.​0142258
120.
Zachariae R, Lyby MS, Ritterband LM, O’Toole MS (2016) Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 30:1–10. doi:10.​1016/​j.​smrv.​2015.​10.​004
121.
Belanger L, Vallieres A, Ivers H, Moreau V, Lavigne G, Morin CM (2007) Meta-analysis of sleep changes in control groups of insomnia treatment trials. J Sleep Res 16:77–84PubMedCrossRef
122.
123.
Mattila T, Stoyanova V, Elferink A, Gispen-de Wied C, de Boer A, Wohlfarth T (2011) Insomnia medication: Do published studies reflect the complete picture of efficacy and safety? Eur Neuropsychopharmacol 21:500–5007PubMedCrossRef
124.
McCall WV, D’Agostino R, Dunn A (2003) A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med 4:57–62PubMedCrossRef
125.
Nissen C, Frase L, Hajak G, Wetter TC (2014) Hypnotika – Stand der Forschung. Nervenarzt 85:67–76PubMedCrossRef
126.
Riemann D, Riemann D, Nissen C (2012) Sleep and psychotropic drugs. In: Morin CM, Espie CA (Hrsg) Oxford handbook of sleep and sleep disorders. Oxford University Press, Oxford
127.
Winkler A, Rief W (2015) Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis. Sleep 38:925–931PubMedPubMedCentral
128.
129.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19:305–322PubMedCrossRef
130.
Glass J, Lanctôt KL, Hermann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331:1–7CrossRef
131.
Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162:225–233
132.
Huedo-Medina T, Kirsch I, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. Br Med J 345:1–13CrossRef
133.
Nowell PD, Mazumdar S, Buysse DJ, Dew MA (1997) Benzodiazepines and zolpidem for chronic insomnia – a meta-analysis of treatment efficacy. JAMA 278:2170–2177PubMedCrossRef
134.
Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816PubMedCrossRef
135.
136.
137.
Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816PubMedCrossRef
138.
Yeung W‑F, Chung K‑F, Yung K‑P, Ng T (2015) Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 19:75–83PubMedCrossRef
139.
Anderson SL, Vande Griend JP (2014) Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm 71:394–402PubMedCrossRef
140.
Cohrs S (2008) Sleep disturbances in patients with schizophrenia. Impact and effects of antipsychotics. CNS Drugs 22:939–962PubMedCrossRef
141.
Monti JM, Monti D (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8:133–148PubMedCrossRef
142.
Vande Griend JP, Anderson SL (2003) Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc 52:210–219CrossRef
143.
144.
Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G (2010) Effectiveness of valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11:505–511PubMedCrossRef
145.
Leach MJ, Page AT (2015) Herbal medicine for insomnia: a systematic review and meta-analysis. Sleep Med Rev 24:1–12PubMedCrossRef
146.
Ni X, Shergis JL, Guo X, Zhang AL, Li Y, Lu C, Xue CC (2015) Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med 16:1462–1481PubMedCrossRef
147.
Braam W, Smits MG, Didden R, Korzilius H, van Geijlswijk IM, Curfs LMG (2009) Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol 51:340–348PubMedCrossRef
148.
Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41–50PubMedCrossRef
149.
Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders – a meta-analysis. J Gen Intern Med 20:1151–1158PubMedPubMedCentralCrossRef
150.
Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J 332:385–393CrossRef
151.
152.
153.
Geijlswijk IM, Korzilius HPLM, Smits MG (2010) The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep 33:1605–1614PubMedPubMedCentral
154.
Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15:385–392PubMedCrossRef
155.
Liu J, Wang L‑N (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66:867–873PubMedCrossRef
156.
157.
Zhang W, Chen XY, Su SW, Jia QZ, Ding T, Zhu ZN, Zhang T (2015) Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Neurol Sci 37(1):57–65. doi:10.​1007/​s10072-015-2357-0 PubMedCrossRef
158.
Chen HY, Shi XY, Ng CS, Chan SM, Yung KK, Zhang QL (2007) Auricular acupuncture treatment for insomnia: a systematic review. J Altern Complement Med 13:669–676PubMedCrossRef
159.
160.
Cooper KL, Relton C (2010) Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 14:329–337PubMedCrossRef
161.
De Niet G, Tiemens B, Lendemeijer B, Hutschemaekers G (2009) Music-assisted relaxation to improve sleep quality: meta-analysis. J Adv Nurs 65:1356–1364PubMedCrossRef
162.
Ernst E (2011) Homeopathy for insomnia and sleeprelated disorders: a systematic review of randomized controlled trials. Focus Altern Complement Ther 16:195–199CrossRef
163.
Hwang E, Shin S (2015) The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. J Altern Complement Med 21:61–68PubMedCrossRef
164.
Jespersen KV, Koenig J, Jennum P, Vuust P (2015) The Cochrane collaboration: music for insomnia in adults (review). John Wiley & Sons, Chichester
165.
Kanen JW, Nazir R, Sedkys K, Pradhan BK (2015) The effects of mindfulness-based interventions on sleep disturbance: a meta-analysis. Adolesc Psychiatry 5:105–115CrossRef
166.
Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW (2015) The effects of physical activity on sleep: a meta-analytic review. J Behav Med 38:427–449PubMedCrossRef
167.
Lam T‑H, Chung K‑F, Yeung W‑F, Yu BY-M, Yung K‑P, Ng TH-Y (2015) Hypnotherapy for insomnia: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 23:719–732PubMedCrossRef
168.
169.
Lee J, Han M, Chung Y, Kim J, Choi J (2011) Effects of foot reflexology on fatigue, sleep and pain: a systematic review and meta-analysis. J Korean Acad Nurs 41:821–833PubMedCrossRef
170.
Lillehei AS, Halcon LL (2014) A systematic review of the effect of inhaled essential oils on sleep. J Altern Complement Med 20:441–451PubMedCrossRef
171.
Van Maanen A, Meijer AM, van der Heijden KB, Ooort FJ (2016) The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev 29:52–62PubMedCrossRef
172.
Wang C‑F, Sun Y‑L, Zang H‑X (2014) Music therapy improves sleep quality in acute and chronic sleep disorders: a meta-analysis of 10 randomized studies. Int J Nurs Stud 51:51–62PubMedCrossRef
173.
Wang F, Lee OE-K, Feng F, Vitiello MV, Wang W, Benson H, Fricchione GL, Denninger JW (2016) The effect of meditative movement on sleep quality: a systematic review. Sleep Med Rev 30:43–52PubMedCrossRef
174.
Wu WW, Kwong E, Lan XY, Jiang XY (2015) The effect of meditative movement intervention on quality of sleep in the elderly: a systematic review and meta-analysis. J Altern Complement Med 21:509–519PubMedCrossRef
175.
Yeung W‑F, Chung K‑F, Poon MM-K, Ho FY-Y, Zhang S‑P, Zhang Z‑J, Ziea ET-C, Wong VT (2012) Acupressure, reflexology, and auricular acupressure for insomnia: a systematic review of randomized controlled trials. Sleep Med 13:971–984PubMedCrossRef
176.
Ancoli-Insrael S, Krystal AD, McCall WV, Schaefer K, Wilson A, Rubens RCR, Roth T (2010) A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep 33:225–234
177.
Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793–799PubMed
178.
Krystal AD, Erman M, Zammit GK, Soubrane C, Roth R (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79–90PubMedPubMedCentral
179.
Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T (2010) Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 33:1553–1561PubMedPubMedCentralCrossRef
180.
Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M (2009) Efficacy and safety of 6‑month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 32:351–360PubMedPubMedCentral
181.
Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ (2014) Safety and efficacy of suvorexant during 1‑year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:461–471PubMedCrossRef
182.
Perlis ML, McCall WV, Krystal AD, Walsh JK (2004) Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 65:1128–1137PubMedCrossRef
183.
Randall S, Roehrs TA, Roth T (2012) Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep 35:1551–1557PubMedPubMedCentral
184.
Roehrs TA, Randall S, Harris E, Maan R, Roth T (2011) Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. Sleep 34:207–212PubMedPubMedCentral
185.
Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6:487–495
186.
Uchimura N, Kamijo A, Takase T (2012) Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study. Ann Gen Psychiatry 11:15. doi:10.​1186/​1744-859X-11-15 PubMedPubMedCentralCrossRef
187.
Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T (2007) Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 30:959–968PubMedPubMedCentral
188.
Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Persistence of cognitive effects after withdrawal from longterm benzodiazepine use: ameta-analysis. Arch Clin Neuropsychol 19:437–454PubMedCrossRef
189.
Dassanayake T, Micie P, Carter G, Jones A (2011) Effects of benzodiazepines, antidepressants, and opoids on driving. A systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 34:125–156PubMedCrossRef
190.
Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371–1378PubMedCrossRef
191.
192.
Hoffmann F, Pfannkuche M, Glaeske G (2008) Hochverbrauch von Zolpidem und Zopiclon. Nervenarzt 79:67–72PubMedCrossRef
193.
Hoffmann F, Scharffetter W, Glaeske G (2009) Verbrauch von Zolpidem und Zo-piclon auf Privatrezepten zwischen 1993 und 2007. Nervenarzt 80:578–583PubMedCrossRef
194.
Hoffmann F (2013) Benefits and risks of benzodiazepines and Z‑drugs: comparison of perceptions of GPs and community pharmacists in Germany. Ger Med Sci 11:1–7
195.
Joya FL, Kripke DF, Loving RT, Dawson A, Kline LE (2009) Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med 5:377–383PubMedPubMedCentral
196.
Kapil V, Green JL, Le Lait C, Wood M, Dargan PI (2014) Misuse of benzodiazepines and Z‑drugs in the UK. Br J Psychiatry 205:407–408PubMedCrossRef
197.
Kraus L, Pabst A (2010) Epidemiologischer Suchtsurvey. Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland. Sucht 56:309–384CrossRef
198.
Kripke DF, Simons RN, Garfinkel L, Hammond EC (1979) Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 36:103–116PubMedCrossRef
199.
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136PubMedCrossRef
200.
Kripke DF (2009) Do hypnotics cause death and cancer? The burden of proof. Sleep Med 10:275–276PubMedCrossRef
201.
Kripke DF (2011) Is insomnia associated with mortality? Sleep 34:557–558
202.
203.
Kyle SD, Morgan K, Spiegelhalder K, Espie CA (2011) No pain, no gain: An exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 12:735–747PubMedCrossRef
204.
Kyle SD, Miller CB, Rogers Z, Siriwardena N, MacMahon KM (2014) Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: Implications for the clinical management of insomnia disorder. Sleep 37:229–237PubMedPubMedCentral
205.
Palmaro A, Dupouy J, Lapeyre-Mestre M (2015) Benzodiazepines and risk of death: results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 25:1566–1577PubMedCrossRef
206.
Rapoport MJ, Lanctot KL, Streiner DL, Bedard M, Vingilis E, Murray B, Schaffer A, Shulman KL, Herrmann N (2009) Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 70:663–673PubMedCrossRef
207.
Soldatos CR, Dikeos DG, Whitehead A (1999) Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 14:287–303PubMedCrossRef
208.
Stranks EK, Crowe SF (2014) The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. J Clin Exp Neuropsychol 36:691–700PubMedCrossRef
209.
210.
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999) Benzodiazepine dependence and withdrawal: myths and management. J Clin Psychopharmacol 19(Suppl 2):23S–29SPubMedCrossRef
211.
Verster JC, Veldhuizen DS, Patat A, Olivier B, Volkerts ER (2006) Hypnotics and riving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 1:63–71PubMedCrossRef
212.
Clinical Guidelines Committee of the American College of Physicians (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. doi:10.​7326/​M15-2175
213.
Moher et al (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the quorom statement. Lancet 27:1890–1900
Metadaten
Titel
S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen
Kapitel „Insomnie bei Erwachsenen“ (AWMF-Registernummer 063-003), Update 2016
verfasst von
Prof. Dr. D. Riemann
E. Baum
S. Cohrs
T. Crönlein
G. Hajak
E. Hertenstein
P. Klose
J. Langhorst
G. Mayer
C. Nissen
T. Pollmächer
S. Rabstein
A. Schlarb
H. Sitter
H.-G. Weeß
T. Wetter
K. Spiegelhalder
Publikationsdatum
27.02.2017
Verlag
Springer Medizin
Schlagwörter
Insomnie
Benzodiazepine
Erschienen in
Somnologie / Ausgabe 1/2017
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI
https://doi.org/10.1007/s11818-016-0097-x

Weitere Artikel der Ausgabe 1/2017

Somnologie 1/2017 Zur Ausgabe

Leserbriefe

Adaptive servoventilation to treat sleep-disordered breathing in cardiac patients

Erratum

Erratum zu: Diagnosestellung und Therapie des Restless-Legs-Syndroms

Schwerpunkt

Die Cortisol-Aufwachreaktion bei Müttern junger Kinder mit Schlafproblemen

Positionspapier

Positionspapier zum Telemonitoring bei schlafbezogenen Atmungsstörungen

Positionspapier

Addendum zum Positionspapier „Schlafmedizin in der Kardiologie. Update 2014“

CME

CME: Schlaf und Schlafstörungen beim alten Menschen

Passend zum Thema

ANZEIGE

Schlafapnoe – Einfach erkennen. Individuell behandeln.

Content Hub

Schlafapnoe verhindert gesunden Schlaf und trägt zur Entstehung bzw. Manifestierung von Komorbiditäten wie Bluthochdruck, Vorhofflimmern und Schlaganfällen bei. Einfache Diagnostiktools helfen, frühzeitig das Risiko zu minimieren und individuelle Therapieansätzen umzusetzen.

ResMed Germany Inc.
ANZEIGE

Der Patient* im Fokus – Patient Empowerment als neuer Ansatz?

Das deutsche Gesundheitssystem steht aktuell vor großen Herausforderungen. Innovative Technologien und Handlungsansätze kollidieren mit fest etablierten Meinungen und Strukturen, der Ruf nach Veränderung wird laut. Auch die Patienten bleiben von dieser Entwicklung nicht unberührt.

ANZEIGE

COMISA - Die komorbide Insomnie bei Schlafapnoe

Insomnie und obstruktive Schlafapnoe (OSA) treten häufiger zusammen auf, als man es basierend auf der jeweiligen Prävalenz in der Bevölkerung vermuten würde [1, 2, 3]. In der Fachliteratur nennt sich diese Komorbidität COMISA – comorbid insomnia and sleep apnea.

Bildnachweise